When it comes to advanced scientific degrees, we field the largest biotechnology group in New England. We aggressively recruit attorneys and technology specialists who develop advanced technology, and who speak the language of inventors and scientists, quickly grasping complex biotechnology matters in a wide spectrum of contexts—including prosecution, post-grant proceedings and litigation, as well as corporate transactions and due diligence. Our clients benefit in the form of efficient and effective intellectual property services.
Our clients include both large and emerging biotech companies such as Biogen, Moderna and Takeda, privately financed growth-phase companies like Ginkgo Bioworks and Oxford Nanopore Technologies, and prestigious academic and research institutions, including Dana Farber Cancer Institute, Harvard Medical School and MIT. We understand the different needs of each client and bring practical solutions to the table.
Our experience is broad and deep, covering areas from antibodies to transgenic technologies—and everything in between. We also call on members of our other practice groups, including Chemical & Materials Technologies and Pharmaceutical, when their specialized knowledge will benefit a client’s project. In addition, our teams are routinely supported by our paralegals and our International Filing Department to contain costs and deliver value.
BROAD RANGE OF IP SERVICES
Our group’s services include: IP strategic planning; patent portfolio development, acquisition and enforcement; studies on patentability, infringement and validity; IP audits and due diligence; licensing and technology transfer; defending and challenging patent validity, including post-grant proceedings; and freedom to operate and competitor analyses.